Yüklüyor......
Proteomic Reveals Reasons for Acquired Drug Resistance in Lung Cancer Derived Brain Metastasis Based on a Newly Established Multi-Organ Microfluidic Chip Model
Anti-tumor drugs can effectively shrink the lesions of primary lung cancer; however, it has limited therapeutic effect on patients with brain metastasis (BM). A BM preclinical model based on a multi-organ microfluidic chip has been established proficiently in our previous work. In this study, the BM...
Kaydedildi:
| Yayımlandı: | Front Bioeng Biotechnol |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7783320/ https://ncbi.nlm.nih.gov/pubmed/33415100 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2020.612091 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|